Their results revealed that the expression level of MG53 in skeletal muscle is not persistently modulated in various preclinical models of insulin resistance, and knocking down MG53 gene expression in muscle cells does not result in impaired insulin response including Akt phosphorylation and glucose uptake. The gene discussed is TRIM72; the disease is Insulin resistance.